Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
9.25%
Price
25.03.26
€306.10
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 9.25%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -3.274% | -3.274% |
| iShares Core DAX® | -3,64 % | -8,78 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % |
| iShares S&P 500 | -2,39 % | -2,78 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat